Insmed To Present at the Nasdaq 47th Investor Conference
Provided By PR Newswire
Last update: Nov 30, 2022
BRIDGEWATER, N.J., Nov. 30, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 47th Investor Conference in London on Wednesday, December 7 at 8:30 a.m. EST/1:30 p.m. GMT.
Read more at prnewswire.com
